Vivacta Expands at Kent Science Park: Faster treatment times at doctor’s surgeries

Vivacta Expands at Kent Science Park: Faster treatment times at doctor’s surgeries

A company offering the prospect of faster treatment times at doctors’ surgeries is doubling the size of its operation at Kent Science Park. Vivacta, the medical diagnostic company developing a highly sensitive Point-of-Care (PoC) immunoassay system, is acquiring a further 6,000ft2 at the Sittingbourne-based Kent Science Park. The company, which already employs more than 20 people, is developing highly sensitive piezo-film sensors, which will enable doctors to get the results of patients’ blood tests without the samples having to leave the surgery. Currently most samples are sent to centralised laboratories for analysis.

The company’s expansion, which will see it take the top floor at Building 100, will enable the development of a pilot manufacturing line for its disposable sensors. It will also lead to new employment opportunities at Vivacta. James Speck, Site Director at Kent Science Park, said: “We are obviously delighted that Vivacta has chosen to expand on the Park as they epitomise the growing community of ambitious technology companies with the potential for rapid-expansion that are choosing to be based here, which is great news for Swale and Kent as a whole.”

Commenting on its decision to expand, Neil Butler, CEO of Vivacta, said, “Since we moved here in 2005 we have built a great team and developed our technology into a product that will enable more effective diagnosis at the Point-of-Care.”

Vivacta recently raised more than £6 million of new financing to drive forward the commercialisation. The financing round was led by AGF Private Equity and HBM BioVentures with follow on investment by both Spark Ventures and Viking Technologies.

Leave a comment below or follow us on Twitter.


Recent News